Who owns HALOZYME THERAPEUTICS, INC.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of HALO from SEC Form 13F filings across 773 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 773 institutions disclosed 126.7M shares of HALOZYME THERAPEUTICS, INC. worth $14.02B — about 111.3% of shares outstanding; the largest disclosed holder is BlackRock, Inc.. Source: SEC Form 13F filings, parsed by EvidInvest.
773
13F holders
$14.02B
value, 2026 filers
111.3%
of shares outstanding (126.7M sh)
170
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of HALO's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 13.7M | $1.51B | 0.0% | 12% | +3.0% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 5.1M | $563.8M | 0.0% | 4.5% | -4.6% |
| 3 | STATE STREET CORP | 5.1M | $559.0M | 0.0% | 4.4% | -2.2% |
| 4 | VANGUARD PORTFOLIO MANAGEMENT LLC | 5.0M | $550.6M | 0.0% | 4.4% | -5.9% |
| 5 | Invesco Ltd. | 3.5M | $390.2M | 0.0% | 3.1% | +11.2% |
| 6 | TWO SIGMA INVESTMENTS, LP | 3.5M | $388.5M | 0.3% | 3.1% | +112.9% |
| 7 | D. E. Shaw & Co., Inc. | 3.4M | $372.4M | 0.2% | 3% | +68.1% |
| 8 | MORGAN STANLEY | 2.9M | $314.7M | 0.0% | 2.5% | +0.6% |
| 9 | Boston Partners | 2.8M | $305.1M | 0.3% | 2.4% | -0.4% |
| 10 | GEODE CAPITAL MANAGEMENT, LLC | 2.4M | $266.6M | 0.0% | 2.1% | -4.2% |
| 11 | BANK OF AMERICA CORP /DE/ | 2.4M | $262.0M | 0.0% | 2.1% | -13.4% |
| 12 | CONGRESS ASSET MANAGEMENT CO | 2.3M | $251.9M | 1.6% | 2% | +85.6% |
| 13 | SNYDER CAPITAL MANAGEMENT L P | 2.2M | $244.3M | 4.8% | 1.9% | -7.7% |
| 14 | DIMENSIONAL FUND ADVISORS LP | 2.1M | $234.2M | 0.0% | 1.9% | +1.5% |
| 15 | FIRST TRUST ADVISORS LP | 1.8M | $200.7M | 0.1% | 1.6% | +28.3% |
| 16 | UBS Group AG | 1.8M | $199.7M | 0.0% | 1.6% | +21.2% |
| 17 | Janus Henderson Group Ltd.NEW | 1.6M | $179.9M | 0.1% | 1.4% | new |
| 18 | WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC | 1.6M | $178.5M | 0.6% | 1.4% | -35.6% |
| 19 | FULLER & THALER ASSET MANAGEMENT, INC. | 1.6M | $177.0M | 0.5% | 1.4% | +7.5% |
| 20 | LOS ANGELES CAPITAL MANAGEMENT LLC | 1.6M | $174.3M | 0.6% | 1.4% | -18.5% |
| 21 | ALLIANCEBERNSTEIN L.P. | 1.5M | $168.7M | 0.1% | 1.3% | -9.9% |
| 22 | JANE STREET GROUP, LLC | 1.5M | $167.7M | 0.0% | 1.3% | +118.6% |
| 23 | LSV ASSET MANAGEMENT | 1.5M | $166.4M | 0.3% | 1.3% | +6.9% |
| 24 | Stephens Investment Management Group LLC | 1.4M | $156.0M | 1.7% | 1.2% | +1.5% |
| 25 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 1.4M | $153.5M | 0.0% | 1.2% | +5.1% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.